[ACM Press the 2013 ACM international symposium - Stateline, Nevada, USA (2013.03.24-2013.03.27)] Proceedings of the 2013 ACM international symposium on International symposium on physical design - ISPD '13 - FF-bond
- 作者Tsai, Chang-Cheng; Shi, Yiyu; Luo, Guojie; Jiang, Iris Hui-Ru
- 文件大小1332.39KB
- 发表时间2013
- DOI10.1145/2451916.2451955
New developments in the treatment of systemic lupus erythematosusKjell Tullus · 2012
New directions in the treatment of systemic lupus erythematosusKalunian, Kenneth; Joan, T. Merrill · Current Medical Research and Opinion · 2009
New therapies for the treatment of systemic lupus erythematosusGullick, Dr Nicola; D’Cruz, Dr David · Expert Opinion on Therapeutic Patents · 2007
Workshop report on some new ideas about the treatment of systemic lupus erythematosusLinnik, M; Staines, NA; Berden, J; Isenberg, DA · Lupus · 2002
Novel development of collagen disease rheumatism medical care. IV. Latest topics. 2. New treatment of the systemic lupus erythematosus.TANAKA, YOSHIYA · Nihon Naika Gakkai Zasshi · 2005
Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus ErythematosusSpecchia, Maria Lucia; de Waure, Chiara; Gualano, Maria Rosaria; Doria, Andrea; Turchetti, Giuseppe; Pippo, Lara; Di Nardo, Francesco; Capizzi, Silvio; Cadeddu, Chiara; Kheiraoui, Flavia; Iaccarino, Luca; Pierotti, Francesca; Palla, Ilaria; Veneziano, Maria Assunta; Gliubizzi, Daniela; Sferrazza, Antonella; Nicolotti, Nicola; Porcasi, Rolando; La Torre, Giuseppe; Di Pietro, Maria Luisa; Ricciardi, Walter · BioMed Research International · 2014
Interleukin 6 (IL-6) Deficiency Delays Lupus Nephritis in MRL-Faslpr Mice: The IL-6 Pathway as a New Therapeutic Target in Treatment of Autoimmune Kidney Disease in Systemic Lupus ErythematosusCASH, H.; RELLE, M.; MENKE, J.; BROCHHAUSEN, C.; JONES, S. A.; TOPLEY, N.; GALLE, P. R.; SCHWARTING, A. · The Journal of Rheumatology · 2010
IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: A possible new treatment?Christian Lood; Maria Allhorn; Rolf Lood; Birgitta Gullstrand; Anders I. Olin; Lars Rönnblom; Lennart Truedsson; Mattias Collin; Anders A. Bengtsson · 2012
Top 10 Things to Know About Lupus Activity MeasuresThanou, Aikaterini; Merrill, Joan T. · Current Rheumatology Reports · 2013
New Trials in Lupus and where Are we GoingThanou, Aikaterini; Merrill, Joan T. · Current Rheumatology Reports · 2018
Impact of heart rate variability, a marker for cardiac health, on lupus disease activityThanou, Aikaterini; Stavrakis, Stavros; Dyer, John W.; Munroe, Melissa E.; James, Judith A.; Merrill, Joan T. · Arthritis Research & Therapy · 2016
Arthritogenic alphaviruses—an overviewSuhrbier, Andreas; Jaffar-Bandjee, Marie-Christine; Gasque, Philippe · Nature Reviews Rheumatology · 2012
Bone remodelling in osteoarthritisBurr, David B.; Gallant, Maxime A. · Nature Reviews Rheumatology · 2012
New developments in osteoimmunologyTakayanagi, Hiroshi · Nature Reviews Rheumatology · 2012
Rheumatoid arthritis: miR-155 mediates inflammationLeah, Emma · Nature Reviews Rheumatology · 2011
Genetics of spondyloarthritis—beyond the MHCReveille, John D. · Nature Reviews Rheumatology · 2012
Bone: RBP-J prevents bone erosionSmith, Katherine · Nature Reviews Rheumatology · 2012
Lupus nephritis: Transatlantic management recommendations comparedHiepe, Falk · Nature Reviews Rheumatology · 2012
Metabolic syndrome meets osteoarthritisZhuo, Qi; Yang, Wei; Chen, Jiying; Wang, Yan · Nature Reviews Rheumatology · 2012